Portolan Capital Management - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 380 filers reported holding VIKING THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
Portolan Capital Management ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$4,210,160
-47.4%
79,422
-18.6%
0.35%
-43.0%
Q1 2024$8,001,806
+26.5%
97,583
-71.3%
0.61%
+10.1%
Q4 2023$6,323,678339,8000.55%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 455,900$2,567,0000.76%
Sio Capital Management, LLC 609,780$3,433,0000.70%
KNOTT DAVID M 218,102$1,228,0000.56%
ArrowMark Colorado Holdings LLC 8,507,790$47,899,0000.37%
Park West Asset Management LLC 1,491,065$8,395,0000.17%
Virtus ETF Advisers LLC 43,966$248,0000.10%
OCCUDO QUANTITATIVE STRATEGIES LP 57,746$325,0000.10%
Cornerstone Capital, Inc. 128,465$723,0000.09%
EXANE DERIVATIVES 51,284$288,716,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 843$5,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders